Correlation Between Blueprint Medicines and Assembly Biosciences

Can any of the company-specific risk be diversified away by investing in both Blueprint Medicines and Assembly Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Blueprint Medicines and Assembly Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Blueprint Medicines Corp and Assembly Biosciences, you can compare the effects of market volatilities on Blueprint Medicines and Assembly Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Blueprint Medicines with a short position of Assembly Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Blueprint Medicines and Assembly Biosciences.

Diversification Opportunities for Blueprint Medicines and Assembly Biosciences

0.93

Correlation Coefficient

Blueprint Medicines  Assembly Biosciences

Almost no diversification

The 3 months correlation between Blueprint and Assembly is 0.93. Overlapping area represents the amount of risk that can be diversified away by holding Blueprint Medicines Corp and Assembly Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Assembly Biosciences and Blueprint Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Blueprint Medicines Corp are associated (or correlated) with Assembly Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Assembly Biosciences has no effect on the direction of Blueprint Medicines i.e., Blueprint Medicines and Assembly Biosciences go up and down completely randomly.

Pair Corralation between Blueprint Medicines and Assembly Biosciences

Given the investment horizon of 90 days Blueprint Medicines is expected to generate 1.3 times less return on investment than Assembly Biosciences. But when comparing it to its historical volatility, Blueprint Medicines Corp is 1.09 times less risky than Assembly Biosciences. It trades about 0.18 of its potential returns per unit of risk. Assembly Biosciences is currently generating about 0.22 of returns per unit of risk over similar time horizon. If you would invest  1,070  in Assembly Biosciences on April 25, 2025 and sell it today you would earn a total of  775.00  from holding Assembly Biosciences or generate 72.43% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Strong
Accuracy	93.55%
Values	Daily Returns

Blueprint Medicines Corp  vs.  Assembly Biosciences

Blueprint Medicines Corp

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Blueprint Medicines Corp are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating primary indicators, Blueprint Medicines exhibited solid returns over the last few months and may actually be approaching a breakup point.

Assembly Biosciences

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Assembly Biosciences are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak primary indicators, Assembly Biosciences sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Blueprint Medicines and Assembly Biosciences

The main advantage of trading using opposite Blueprint Medicines and Assembly Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Blueprint Medicines position performs unexpectedly, Assembly Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Assembly Biosciences will offset losses from the drop in Assembly Biosciences' long position.

The idea behind Blueprint Medicines Corp and Assembly Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.